Listed

Boston Scientific Corp

BSXNYSECIK 885725HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$5.44bn, Q2 FY2026
Operating income$1.18bn, Q2 FY2026
Net income$905.0m, Q2 FY2026
Boston Scientific Corp, income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m3,527Revenue, Q3 FY2023, three months to 2023-09-30$3.53bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure3,725Revenue, Q4 FY2023, three months to 2023-12-31$3.73bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure3,856Revenue, Q1 FY2024, three months to 2024-03-31$3.86bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure4,120Revenue, Q2 FY2024, three months to 2024-06-30$4.12bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure4,209Revenue, Q3 FY2024, three months to 2024-09-30$4.21bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure4,561Revenue, Q4 FY2024, three months to 2024-12-31$4.56bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure4,663Revenue, Q1 FY2025, three months to 2025-03-31$4.66bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure5,061Revenue, Q2 FY2025, three months to 2025-06-30$5.06bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure5,065Revenue, Q3 FY2025, three months to 2025-09-30$5.07bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure5,286Revenue, Q4 FY2025, three months to 2025-12-31$5.29bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure5,203Revenue, Q1 FY2026, three months to 2026-03-31$5.20bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure5,442Revenue, Q2 FY2026, three months to 2026-06-30$5.44bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Cost of revenue$m1,101Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.10bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure1,147Cost of revenue, Q4 FY2023, three months to 2023-12-31$1.15bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,209Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.21bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure1,270Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.27bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure1,312Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.31bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure1,466Cost of revenue, Q4 FY2024, three months to 2024-12-31$1.47bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,453Cost of revenue, Q1 FY2025, three months to 2025-03-31$1.45bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,637Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.64bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure1,523Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.52bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure1,608Cost of revenue, Q4 FY2025, three months to 2025-12-31$1.61bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,590Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.59bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,594Cost of revenue, Q2 FY2026, three months to 2026-06-30$1.59bn. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Gross profit$m2,426Gross profit, Q3 FY2023, three months to 2023-09-30$2.43bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure2,579Gross profit, Q4 FY2023, three months to 2023-12-31$2.58bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure2,648Gross profit, Q1 FY2024, three months to 2024-03-31$2.65bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure2,850Gross profit, Q2 FY2024, three months to 2024-06-30$2.85bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure2,897Gross profit, Q3 FY2024, three months to 2024-09-30$2.90bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure3,095Gross profit, Q4 FY2024, three months to 2024-12-31$3.10bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure3,210Gross profit, Q1 FY2025, three months to 2025-03-31$3.21bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure3,424Gross profit, Q2 FY2025, three months to 2025-06-30$3.42bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure3,542Gross profit, Q3 FY2025, three months to 2025-09-30$3.54bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure3,679Gross profit, Q4 FY2025, three months to 2025-12-31$3.68bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure3,614Gross profit, Q1 FY2026, three months to 2026-03-31$3.61bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure3,848Gross profit, Q2 FY2026, three months to 2026-06-30$3.85bn. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Selling, general and administrative$m1,242Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$1.24bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure1,379Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$1.38bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,364Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$1.36bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure1,446Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$1.45bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure1,562Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$1.56bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure1,612Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$1.61bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,597Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$1.60bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,716Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$1.72bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure1,741Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$1.74bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure1,834Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$1.83bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,781Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$1.78bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,803Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$1.80bn. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Operating income$m693Operating income, Q3 FY2023, three months to 2023-09-30$693.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure584Operating income, Q4 FY2023, three months to 2023-12-31$584.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure675Operating income, Q1 FY2024, three months to 2024-03-31$675.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure520Operating income, Q2 FY2024, three months to 2024-06-30$520.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure733Operating income, Q3 FY2024, three months to 2024-09-30$733.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure675Operating income, Q4 FY2024, three months to 2024-12-31$675.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure921Operating income, Q1 FY2025, three months to 2025-03-31$921.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure819Operating income, Q2 FY2025, three months to 2025-06-30$819.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure1,048Operating income, Q3 FY2025, three months to 2025-09-30$1.05bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure825Operating income, Q4 FY2025, three months to 2025-12-31$825.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,101Operating income, Q1 FY2026, three months to 2026-03-31$1.10bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,178Operating income, Q2 FY2026, three months to 2026-06-30$1.18bn. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Interest expense$m66.0Interest expense, Q3 FY2023, three months to 2023-09-30$66.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure65.0Interest expense, Q4 FY2023, three months to 2023-12-31$65.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure69.0Interest expense, Q1 FY2024, three months to 2024-03-31$69.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure77.0Interest expense, Q2 FY2024, three months to 2024-06-30$77.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure79.0Interest expense, Q3 FY2024, three months to 2024-09-30$79.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure80.0Interest expense, Q4 FY2024, three months to 2024-12-31$80.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure82.0Interest expense, Q1 FY2025, three months to 2025-03-31$82.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure90.0Interest expense, Q2 FY2025, three months to 2025-06-30$90.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure87.0Interest expense, Q3 FY2025, three months to 2025-09-30$87.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure90.0Interest expense, Q4 FY2025, three months to 2025-12-31$90.0m. XBRL concept us-gaap:InterestExpense. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure90.0Interest expense, Q1 FY2026, three months to 2026-03-31$90.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure96.0Interest expense, Q2 FY2026, three months to 2026-06-30$96.0m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Income tax$m105Income tax, Q3 FY2023, three months to 2023-09-30$105.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure1.0Income tax, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure115Income tax, Q1 FY2024, three months to 2024-03-31$115.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure98.0Income tax, Q2 FY2024, three months to 2024-06-30$98.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure200Income tax, Q3 FY2024, three months to 2024-09-30$200.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure23.0Income tax, Q4 FY2024, three months to 2024-12-31$23.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure133Income tax, Q1 FY2025, three months to 2025-03-31$133.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure146Income tax, Q2 FY2025, three months to 2025-06-30$146.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure183Income tax, Q3 FY2025, three months to 2025-09-30$183.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure30.0Income tax, Q4 FY2025, three months to 2025-12-31$30.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure(176)Income tax, Q1 FY2026, three months to 2026-03-31−$176.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure155Income tax, Q2 FY2026, three months to 2026-06-30$155.0m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Net income$m504Net income, Q3 FY2023, three months to 2023-09-30$504.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure504Net income, Q4 FY2023, three months to 2023-12-31$504.0m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure493Net income, Q1 FY2024, three months to 2024-03-31$493.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure322Net income, Q2 FY2024, three months to 2024-06-30$322.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure468Net income, Q3 FY2024, three months to 2024-09-30$468.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure562Net income, Q4 FY2024, three months to 2024-12-31$562.0m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure672Net income, Q1 FY2025, three months to 2025-03-31$672.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure795Net income, Q2 FY2025, three months to 2025-06-30$795.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure755Net income, Q3 FY2025, three months to 2025-09-30$755.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure670Net income, Q4 FY2025, three months to 2025-12-31$670.0m. XBRL concept us-gaap:ProfitLoss. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure1,339Net income, Q1 FY2026, three months to 2026-03-31$1.34bn. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure905Net income, Q2 FY2026, three months to 2026-06-30$905.0m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Diluted EPS$ per share0.34Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figurenot reported0.33Diluted EPS, Q1 FY2024, three months to 2024-03-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure0.22Diluted EPS, Q2 FY2024, three months to 2024-06-30$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure0.32Diluted EPS, Q3 FY2024, three months to 2024-09-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figurenot reported0.45Diluted EPS, Q1 FY2025, three months to 2025-03-31$0.45 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure0.53Diluted EPS, Q2 FY2025, three months to 2025-06-30$0.53 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure0.51Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.51 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figurenot reported0.90Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.90 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure0.61Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.61 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Basic EPS$ per share0.34Basic EPS, Q3 FY2023, three months to 2023-09-30$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figurenot reported0.34Basic EPS, Q1 FY2024, three months to 2024-03-31$0.34 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure0.22Basic EPS, Q2 FY2024, three months to 2024-06-30$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure0.32Basic EPS, Q3 FY2024, three months to 2024-09-30$0.32 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figurenot reported0.46Basic EPS, Q1 FY2025, three months to 2025-03-31$0.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure0.54Basic EPS, Q2 FY2025, three months to 2025-06-30$0.54 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure0.51Basic EPS, Q3 FY2025, three months to 2025-09-30$0.51 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figurenot reported0.90Basic EPS, Q1 FY2026, three months to 2026-03-31$0.90 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure0.62Basic EPS, Q2 FY2026, three months to 2026-06-30$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure

Balance sheet

Cash and equivalents$539.0m, Q2 FY2026
Shareholders' equity$24.93bn, Q2 FY2026
Boston Scientific Corp, balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$bn1.0Cash and equivalents, Q3 FY2023, at 2023-09-30$952.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure0.9Cash and equivalents, FY2023, at 2023-12-31$865.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0000885725-26-000010.Report this figure2.3Cash and equivalents, Q1 FY2024, at 2024-03-31$2.33bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure2.9Cash and equivalents, Q2 FY2024, at 2024-06-30$2.91bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure2.5Cash and equivalents, Q3 FY2024, at 2024-09-30$2.50bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure0.4Cash and equivalents, FY2024, at 2024-12-31$414.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-17, accession 0000885725-26-000010.Report this figure0.7Cash and equivalents, Q1 FY2025, at 2025-03-31$725.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure0.5Cash and equivalents, Q2 FY2025, at 2025-06-30$534.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure1.3Cash and equivalents, Q3 FY2025, at 2025-09-30$1.27bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure2.0Cash and equivalents, FY2025, at 2025-12-31$1.97bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure1.5Cash and equivalents, Q1 FY2026, at 2026-03-31$1.45bn. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure0.5Cash and equivalents, Q2 FY2026, at 2026-06-30$539.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Current assets$bn6.5Current assets, Q3 FY2023, at 2023-09-30$6.50bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-01, accession 0000885725-23-000048.Report this figure6.5Current assets, FY2023, at 2023-12-31$6.51bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-18, accession 0000885725-25-000011.Report this figure8.2Current assets, Q1 FY2024, at 2024-03-31$8.19bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-01, accession 0000885725-24-000046.Report this figure9.0Current assets, Q2 FY2024, at 2024-06-30$8.99bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0000885725-24-000068.Report this figure8.8Current assets, Q3 FY2024, at 2024-09-30$8.76bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure6.9Current assets, FY2024, at 2024-12-31$6.92bn. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-17, accession 0000885725-26-000010.Report this figure7.3Current assets, Q1 FY2025, at 2025-03-31$7.33bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure7.1Current assets, Q2 FY2025, at 2025-06-30$7.12bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure8.0Current assets, Q3 FY2025, at 2025-09-30$8.04bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure8.8Current assets, FY2025, at 2025-12-31$8.79bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure8.7Current assets, Q1 FY2026, at 2026-03-31$8.68bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure8.0Current assets, Q2 FY2026, at 2026-06-30$7.97bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Total assets$bn34.0Total assets, Q3 FY2023, at 2023-09-30$34.04bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-01, accession 0000885725-23-000048.Report this figure35.1Total assets, FY2023, at 2023-12-31$35.14bn. XBRL concept us-gaap:Assets. 10-K filed 2025-02-18, accession 0000885725-25-000011.Report this figure36.7Total assets, Q1 FY2024, at 2024-03-31$36.67bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-01, accession 0000885725-24-000046.Report this figure37.1Total assets, Q2 FY2024, at 2024-06-30$37.11bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0000885725-24-000068.Report this figure38.1Total assets, Q3 FY2024, at 2024-09-30$38.08bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure39.4Total assets, FY2024, at 2024-12-31$39.40bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-17, accession 0000885725-26-000010.Report this figure40.1Total assets, Q1 FY2025, at 2025-03-31$40.14bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure41.6Total assets, Q2 FY2025, at 2025-06-30$41.56bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure42.7Total assets, Q3 FY2025, at 2025-09-30$42.71bn. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure43.7Total assets, FY2025, at 2025-12-31$43.67bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure44.4Total assets, Q1 FY2026, at 2026-03-31$44.35bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure45.2Total assets, Q2 FY2026, at 2026-06-30$45.22bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Current liabilities$bn4.6Current liabilities, Q3 FY2023, at 2023-09-30$4.58bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-01, accession 0000885725-23-000048.Report this figure4.9Current liabilities, FY2023, at 2023-12-31$4.93bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-18, accession 0000885725-25-000011.Report this figure4.9Current liabilities, Q1 FY2024, at 2024-03-31$4.92bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-01, accession 0000885725-24-000046.Report this figure5.6Current liabilities, Q2 FY2024, at 2024-06-30$5.58bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0000885725-24-000068.Report this figure5.9Current liabilities, Q3 FY2024, at 2024-09-30$5.91bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure6.4Current liabilities, FY2024, at 2024-12-31$6.40bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-17, accession 0000885725-26-000010.Report this figure5.1Current liabilities, Q1 FY2025, at 2025-03-31$5.06bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure5.2Current liabilities, Q2 FY2025, at 2025-06-30$5.19bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure5.3Current liabilities, Q3 FY2025, at 2025-09-30$5.33bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure5.4Current liabilities, FY2025, at 2025-12-31$5.44bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure4.6Current liabilities, Q1 FY2026, at 2026-03-31$4.57bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure6.4Current liabilities, Q2 FY2026, at 2026-06-30$6.43bn. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Long-term debt$bnnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$bn0.5Current portion of debt, Q3 FY2023, at 2023-09-30$513.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2023-11-01, accession 0000885725-23-000048.Report this figure0.5Current portion of debt, FY2023, at 2023-12-31$531.0m. XBRL concept us-gaap:DebtCurrent. 10-K filed 2025-02-18, accession 0000885725-25-000011.Report this figure1.1Current portion of debt, Q1 FY2024, at 2024-03-31$1.08bn. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2024-05-01, accession 0000885725-24-000046.Report this figure1.6Current portion of debt, Q2 FY2024, at 2024-06-30$1.58bn. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2024-08-01, accession 0000885725-24-000068.Report this figure1.7Current portion of debt, Q3 FY2024, at 2024-09-30$1.65bn. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure1.8Current portion of debt, FY2024, at 2024-12-31$1.78bn. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-02-17, accession 0000885725-26-000010.Report this figure0.8Current portion of debt, Q1 FY2025, at 2025-03-31$777.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure0.5Current portion of debt, Q2 FY2025, at 2025-06-30$480.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure0.5Current portion of debt, Q3 FY2025, at 2025-09-30$483.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure0.3Current portion of debt, FY2025, at 2025-12-31$299.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure0.0Current portion of debt, Q1 FY2026, at 2026-03-31$41.0m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1.7Current portion of debt, Q2 FY2026, at 2026-06-30$1.71bn. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure
Shareholders' equity$bn18.9Shareholders' equity, Q3 FY2023, at 2023-09-30$18.89bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure19.3Shareholders' equity, FY2023, at 2023-12-31$19.28bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2025-02-18, accession 0000885725-25-000011.Report this figure19.9Shareholders' equity, Q1 FY2024, at 2024-03-31$19.93bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-05-01, accession 0000885725-24-000046.Report this figure20.4Shareholders' equity, Q2 FY2024, at 2024-06-30$20.37bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure20.7Shareholders' equity, Q3 FY2024, at 2024-09-30$20.71bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure21.8Shareholders' equity, FY2024, at 2024-12-31$21.77bn. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-17, accession 0000885725-26-000010.Report this figure22.2Shareholders' equity, Q1 FY2025, at 2025-03-31$22.21bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure22.4Shareholders' equity, Q2 FY2025, at 2025-06-30$22.42bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure23.4Shareholders' equity, Q3 FY2025, at 2025-09-30$23.39bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure24.2Shareholders' equity, FY2025, at 2025-12-31$24.23bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure25.9Shareholders' equity, Q1 FY2026, at 2026-03-31$25.86bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure24.9Shareholders' equity, Q2 FY2026, at 2026-06-30$24.93bn. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure

Cash flow

Operating cash flow$1.47bn, Q2 FY2026
Capital expenditure$195.0m, Q2 FY2026
Boston Scientific Corp, cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m698Operating cash flow, Q3 FY2023, three months to 2023-09-30$698.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-01, accession 0000885725-24-000073. Derived: 9-month figure less the 6-month figure.Report this figure957Operating cash flow, Q4 FY2023, three months to 2023-12-31$957.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure164Operating cash flow, Q1 FY2024, three months to 2024-03-31$164.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure813Operating cash flow, Q2 FY2024, three months to 2024-06-30$813.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-01, accession 0000885725-25-000041. Derived: 6-month figure less the 3-month figure.Report this figure1,002Operating cash flow, Q3 FY2024, three months to 2024-09-30$1.00bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0000885725-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure1,456Operating cash flow, Q4 FY2024, three months to 2024-12-31$1.46bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure541Operating cash flow, Q1 FY2025, three months to 2025-03-31$541.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,286Operating cash flow, Q2 FY2025, three months to 2025-06-30$1.29bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0000885725-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure1,343Operating cash flow, Q3 FY2025, three months to 2025-09-30$1.34bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-03, accession 0000885725-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure1,364Operating cash flow, Q4 FY2025, three months to 2025-12-31$1.36bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure348Operating cash flow, Q1 FY2026, three months to 2026-03-31$348.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,474Operating cash flow, Q2 FY2026, three months to 2026-06-30$1.47bn. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-03, accession 0000885725-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m190Capital expenditure, Q3 FY2023, three months to 2023-09-30$190.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-01, accession 0000885725-24-000073. Derived: 9-month figure less the 6-month figure.Report this figure267Capital expenditure, Q4 FY2023, three months to 2023-12-31$267.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure179Capital expenditure, Q1 FY2024, three months to 2024-03-31$179.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure155Capital expenditure, Q2 FY2024, three months to 2024-06-30$155.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-01, accession 0000885725-25-000041. Derived: 6-month figure less the 3-month figure.Report this figure179Capital expenditure, Q3 FY2024, three months to 2024-09-30$179.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0000885725-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure277Capital expenditure, Q4 FY2024, three months to 2024-12-31$277.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure187Capital expenditure, Q1 FY2025, three months to 2025-03-31$187.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure157Capital expenditure, Q2 FY2025, three months to 2025-06-30$157.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0000885725-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure181Capital expenditure, Q3 FY2025, three months to 2025-09-30$181.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-03, accession 0000885725-25-000050. Derived: 9-month figure less the 6-month figure.Report this figure351Capital expenditure, Q4 FY2025, three months to 2025-12-31$351.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-17, accession 0000885725-26-000010. Derived: 12-month figure less the 9-month figure.Report this figure177Capital expenditure, Q1 FY2026, three months to 2026-03-31$177.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure195Capital expenditure, Q2 FY2026, three months to 2026-06-30$195.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-03, accession 0000885725-26-000053. Derived: 6-month figure less the 3-month figure.Report this figure
Dividends paid$m0.0Dividends paid, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-11-01, accession 0000885725-24-000073. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2023, three months to 2023-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2025-02-18, accession 0000885725-25-000011. Derived: 12-month figure less the 9-month figure.Report this figure0.0Dividends paid, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-05-01, accession 0000885725-24-000046.Report this figure0.0Dividends paid, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-08-01, accession 0000885725-24-000068. Derived: 6-month figure less the 3-month figure.Report this figure0.0Dividends paid, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsOfDividends. 10-Q filed 2024-11-01, accession 0000885725-24-000073. Derived: 9-month figure less the 6-month figure.Report this figure0.0Dividends paid, Q4 FY2024, three months to 2024-12-31$0. XBRL concept us-gaap:PaymentsOfDividends. 10-K filed 2025-02-18, accession 0000885725-25-000011. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)1.47bn, Q2 FY2026
Boston Scientific Corp, shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1,440Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,440,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-01, accession 0000885725-23-000048.Report this figure1,446Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,446,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-01, accession 0000885725-24-000046.Report this figure1,456Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,456,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0000885725-24-000068.Report this figure1,475Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,475,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-01, accession 0000885725-24-000073.Report this figure1,482Diluted shares (weighted), Q1 FY2024, three months to 2024-03-311,481,700,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0000885725-25-000026.Report this figure1,484Diluted shares (weighted), Q2 FY2024, three months to 2024-06-301,484,200,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-01, accession 0000885725-25-000041.Report this figure1,487Diluted shares (weighted), Q3 FY2024, three months to 2024-09-301,487,400,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure1,493Diluted shares (weighted), Q1 FY2025, three months to 2025-03-311,493,100,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,494Diluted shares (weighted), Q2 FY2025, three months to 2025-06-301,493,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure1,496Diluted shares (weighted), Q3 FY2025, three months to 2025-09-301,495,500,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-03, accession 0000885725-25-000050.Report this figure1,495Diluted shares (weighted), Q1 FY2026, three months to 2026-03-311,495,000,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-01, accession 0000885725-26-000033.Report this figure1,475Diluted shares (weighted), Q2 FY2026, three months to 2026-06-301,474,800,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure

Shares outstanding: 1.45bnShares outstanding, period not labelled, at 2026-07-301,449,229,526 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-03, accession 0000885725-26-000053.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 3, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.